Cargando…

The Phenotype of the C9ORF72 Expansion Carriers According to Revised Criteria for bvFTD

BACKGROUND: The C9ORF72 expansion is one of the most common genetic etiologies observed with behavioural variant frontotemporal dementia (bvFTD). Revised diagnostic criteria for bvFTD (FTDC) were recently introduced but only a few studies have evaluated the accuracy of these criteria. OBJECTIVE: The...

Descripción completa

Detalles Bibliográficos
Autores principales: Solje, Eino, Aaltokallio, Heidi, Koivumaa-Honkanen, Heli, Suhonen, Noora M., Moilanen, Virpi, Kiviharju, Anna, Traynor, Bryan, Tienari, Pentti J., Hartikainen, Päivi, Remes, Anne M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493025/
https://www.ncbi.nlm.nih.gov/pubmed/26146826
http://dx.doi.org/10.1371/journal.pone.0131817
_version_ 1782379848015020032
author Solje, Eino
Aaltokallio, Heidi
Koivumaa-Honkanen, Heli
Suhonen, Noora M.
Moilanen, Virpi
Kiviharju, Anna
Traynor, Bryan
Tienari, Pentti J.
Hartikainen, Päivi
Remes, Anne M.
author_facet Solje, Eino
Aaltokallio, Heidi
Koivumaa-Honkanen, Heli
Suhonen, Noora M.
Moilanen, Virpi
Kiviharju, Anna
Traynor, Bryan
Tienari, Pentti J.
Hartikainen, Päivi
Remes, Anne M.
author_sort Solje, Eino
collection PubMed
description BACKGROUND: The C9ORF72 expansion is one of the most common genetic etiologies observed with behavioural variant frontotemporal dementia (bvFTD). Revised diagnostic criteria for bvFTD (FTDC) were recently introduced but only a few studies have evaluated the accuracy of these criteria. OBJECTIVE: The objective of the study was to evaluate the applicability of the FTDC criteria and assess the psychiatric history of these patients. METHODS: The study examined 36 patients carrying the C9ORF72 expansion and suffering from bvFTD (N = 32) or from bvFTD with motor neuron disease (bvFTD-MND, N = 4). Neuropsychological, neuropsychiatric, structural brain imaging and PET/SPECT data were evaluated. RESULTS: We found 0.75 sensitivity (SD 0.44, 95%CI 0.57–0.87) for possible bvFTD and 0.64 (SD 0.44, 95%CI 0.57–0.87) for probable bvFTD. The sensitivity was even higher in bvFTD patients without MND, i.e., 0.81 for possible bvFTD and 0.69 for probable bvFTD. PET/SPECT was normal in 17.6% of scanned patients with bvFTD. A history of psychiatric symptoms (psychotic and/or mood symptoms) was detected in 61% of cases. CONCLUSIONS: The FTDC possible and probable bvFTD criteria seem to identify the majority of the C9ORF72 expansion carriers with bvFTD, even though they exhibit only a limited number of behavioral criteria but a significant amount of psychiatric symptoms. The presence of a normal PET/SPECT does not exclude the possibility the C9ORF72 associated bvFTD.
format Online
Article
Text
id pubmed-4493025
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-44930252015-07-15 The Phenotype of the C9ORF72 Expansion Carriers According to Revised Criteria for bvFTD Solje, Eino Aaltokallio, Heidi Koivumaa-Honkanen, Heli Suhonen, Noora M. Moilanen, Virpi Kiviharju, Anna Traynor, Bryan Tienari, Pentti J. Hartikainen, Päivi Remes, Anne M. PLoS One Research Article BACKGROUND: The C9ORF72 expansion is one of the most common genetic etiologies observed with behavioural variant frontotemporal dementia (bvFTD). Revised diagnostic criteria for bvFTD (FTDC) were recently introduced but only a few studies have evaluated the accuracy of these criteria. OBJECTIVE: The objective of the study was to evaluate the applicability of the FTDC criteria and assess the psychiatric history of these patients. METHODS: The study examined 36 patients carrying the C9ORF72 expansion and suffering from bvFTD (N = 32) or from bvFTD with motor neuron disease (bvFTD-MND, N = 4). Neuropsychological, neuropsychiatric, structural brain imaging and PET/SPECT data were evaluated. RESULTS: We found 0.75 sensitivity (SD 0.44, 95%CI 0.57–0.87) for possible bvFTD and 0.64 (SD 0.44, 95%CI 0.57–0.87) for probable bvFTD. The sensitivity was even higher in bvFTD patients without MND, i.e., 0.81 for possible bvFTD and 0.69 for probable bvFTD. PET/SPECT was normal in 17.6% of scanned patients with bvFTD. A history of psychiatric symptoms (psychotic and/or mood symptoms) was detected in 61% of cases. CONCLUSIONS: The FTDC possible and probable bvFTD criteria seem to identify the majority of the C9ORF72 expansion carriers with bvFTD, even though they exhibit only a limited number of behavioral criteria but a significant amount of psychiatric symptoms. The presence of a normal PET/SPECT does not exclude the possibility the C9ORF72 associated bvFTD. Public Library of Science 2015-07-06 /pmc/articles/PMC4493025/ /pubmed/26146826 http://dx.doi.org/10.1371/journal.pone.0131817 Text en © 2015 Solje et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Solje, Eino
Aaltokallio, Heidi
Koivumaa-Honkanen, Heli
Suhonen, Noora M.
Moilanen, Virpi
Kiviharju, Anna
Traynor, Bryan
Tienari, Pentti J.
Hartikainen, Päivi
Remes, Anne M.
The Phenotype of the C9ORF72 Expansion Carriers According to Revised Criteria for bvFTD
title The Phenotype of the C9ORF72 Expansion Carriers According to Revised Criteria for bvFTD
title_full The Phenotype of the C9ORF72 Expansion Carriers According to Revised Criteria for bvFTD
title_fullStr The Phenotype of the C9ORF72 Expansion Carriers According to Revised Criteria for bvFTD
title_full_unstemmed The Phenotype of the C9ORF72 Expansion Carriers According to Revised Criteria for bvFTD
title_short The Phenotype of the C9ORF72 Expansion Carriers According to Revised Criteria for bvFTD
title_sort phenotype of the c9orf72 expansion carriers according to revised criteria for bvftd
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493025/
https://www.ncbi.nlm.nih.gov/pubmed/26146826
http://dx.doi.org/10.1371/journal.pone.0131817
work_keys_str_mv AT soljeeino thephenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd
AT aaltokallioheidi thephenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd
AT koivumaahonkanenheli thephenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd
AT suhonennooram thephenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd
AT moilanenvirpi thephenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd
AT kiviharjuanna thephenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd
AT traynorbryan thephenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd
AT tienaripenttij thephenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd
AT hartikainenpaivi thephenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd
AT remesannem thephenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd
AT soljeeino phenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd
AT aaltokallioheidi phenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd
AT koivumaahonkanenheli phenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd
AT suhonennooram phenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd
AT moilanenvirpi phenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd
AT kiviharjuanna phenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd
AT traynorbryan phenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd
AT tienaripenttij phenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd
AT hartikainenpaivi phenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd
AT remesannem phenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd